Adeno-associated virus (AAV) vectors: will they work?
作者信息
Muzyczka N
出版信息
J Clin Invest. 1994 Oct;94(4):1351. doi: 10.1172/JCI117468.
Abstract
摘要
相似文献
1
Adeno-associated virus (AAV) vectors: will they work?腺相关病毒（AAV）载体：它们会起作用吗？
J Clin Invest. 1994 Oct;94(4):1351. doi: 10.1172/JCI117468.
2
Receptor targeting of adeno-associated virus vectors.腺相关病毒载体的受体靶向
Gene Ther. 2003 Jul;10(14):1142-51. doi: 10.1038/sj.gt.3301976.
3
Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.动物和人类对腺相关病毒载体的免疫：持续存在的挑战。
Gene Ther. 2008 Jun;15(11):808-16. doi: 10.1038/gt.2008.54. Epub 2008 Apr 3.
4
Production and characterization of adeno-associated viral vectors.腺相关病毒载体的生产与特性分析
Nat Protoc. 2006;1(3):1412-28. doi: 10.1038/nprot.2006.207.
5
Manufacturing and characterizing AAV-based vectors for use in clinical studies.制造和表征用于临床研究的基于腺相关病毒的载体。
Gene Ther. 2008 Jun;15(11):840-8. doi: 10.1038/gt.2008.65. Epub 2008 Apr 17.
6
AAV vectors for hemophilia B gene therapy.用于B型血友病基因治疗的腺相关病毒载体
Mt Sinai J Med. 2004 Oct;71(5):305-13.
7
Clinical gene therapy using recombinant adeno-associated virus vectors.使用重组腺相关病毒载体的临床基因治疗。
Gene Ther. 2008 Jun;15(11):858-63. doi: 10.1038/gt.2008.68. Epub 2008 Apr 17.
8
Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.通过腺相关病毒载体的转录和转导靶向作用改善心脏基因转移。
Cardiovasc Res. 2006 Apr 1;70(1):70-8. doi: 10.1016/j.cardiores.2005.12.017. Epub 2006 Jan 31.
9
Current development of adeno-associated viral vectors.腺相关病毒载体的当前发展情况。
Drug News Perspect. 2005 Jun;18(5):311-6. doi: 10.1358/dnp.2005.18.5.917326.
10
Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.利用重组腺相关病毒载体治疗杜氏肌营养不良症的基因治疗策略。
Mol Ther. 2006 Feb;13(2):241-9. doi: 10.1016/j.ymthe.2005.11.001. Epub 2005 Dec 19.
引用本文的文献
1
NADH dehydrogenases: from basic science to biomedicine.NADH脱氢酶：从基础科学到生物医学
J Bioenerg Biomembr. 2001 Jun;33(3):233-42. doi: 10.1023/a:1010787004053.
2
Size does matter: overcoming the adeno-associated virus packaging limit.大小至关重要：克服腺相关病毒包装限制。
Respir Res. 2000;1(1):16-8. doi: 10.1186/rr6. Epub 2000 Jul 5.
3
Gene therapy: here to stay.基因疗法：将持续存在。
CMAJ. 1995 May 15;152(10):1605-13.
本文引用的文献
1
Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells.腺相关病毒2介导的基因转移至小鼠造血祖细胞中。
Exp Hematol. 1993 Jul;21(7):928-33.
2
Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.利用重组腺相关病毒载体对人类造血细胞中的范可尼贫血进行表型校正。
J Clin Invest. 1994 Oct;94(4):1440-8. doi: 10.1172/JCI117481.
3
Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.使用腺相关病毒载体实现囊性纤维化跨膜传导调节因子在体内的稳定表达。
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10613-7. doi: 10.1073/pnas.90.22.10613.
4
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.腺相关病毒作为哺乳动物DNA克隆载体的应用：将新霉素抗性导入哺乳动物组织培养细胞。
Proc Natl Acad Sci U S A. 1984 Oct;81(20):6466-70. doi: 10.1073/pnas.81.20.6466.
5
Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector.腺相关病毒载体介导的基因向造血祖细胞的转移。
Virology. 1988 Feb;162(2):483-6. doi: 10.1016/0042-6822(88)90491-6.
6
Use of adeno-associated virus as a general transduction vector for mammalian cells.
Curr Top Microbiol Immunol. 1992;158:97-129. doi: 10.1007/978-3-642-75608-5_5.
Zotero 插件